Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

In a prospective cohort study 8466 women attending routine cervical cancer screening were recruited. Colposcopy was performed on women with any degree of atypia on cytology and/or a positive high-risk human papillomavirus (HPV)-DNA test (HC2; Hybrid Capture 2(©)), and for a randomly selected sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Petry, K-U, Menton, S, Menton, M, van Loenen-Frosch, F, de Carvalho Gomes, H, Holz, B, Schopp, B, Garbrecht-Buettner, S, Davies, P, Boehmer, G, van den Akker, E, Iftner, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377109/
https://www.ncbi.nlm.nih.gov/pubmed/12771924
http://dx.doi.org/10.1038/sj.bjc.6600918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377109/
https://www.ncbi.nlm.nih.gov/pubmed/12771924
http://dx.doi.org/10.1038/sj.bjc.6600918

Ejemplares similares